company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20950034.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20950034.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,556235.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,713628.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2211784.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8395685.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9072702.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9072702.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-584358.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45875682.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49173134.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2713094.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2713094.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1631.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,102721.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101090.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101090.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6258518.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14037729.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14037729.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,549759.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,786189.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1321583.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5555984.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8467380.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8467380.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-436192.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32418014.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43495880.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10631674.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10641674.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1665.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,64064.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,62399.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,62399.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2236693.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2306000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2306000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,578000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,700000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,869000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8980000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9139000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9139000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-331000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33067000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43832000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10434000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10434000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:47:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1303000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11730536.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11730536.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,584006.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,677641.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-352371.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2329661.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8491599.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8491599.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-305348.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26109455.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30515515.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4100712.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4100712.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2433.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,134997.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,132564.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,132564.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4258323.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11944719.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11944719.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,470889.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,634515.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-34334.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3949581.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6924068.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6924068.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-185427.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32787897.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45217240.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12243916.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12243916.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1770.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,311586.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,309816.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,309816.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5629664.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14060745.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14060745.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,466105.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,490844.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5132705.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-583242.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8554333.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8554333.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-720225.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58623648.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18877245.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40466628.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40466628.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,203.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,50000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-455583.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,582000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50126620.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50126620.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1105659.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10722000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10722000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,446000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,568000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3817000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5324000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11215000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11215000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-236000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11807000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21829000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9786000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9786000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,694000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,694000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,694000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q1,2012-01-01,2012-03-31,2012-05-08 15:47:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-735000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14660000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14660000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,407000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,634000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7317000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3871000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2431000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2431000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42774000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38985000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3884000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3884000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2504000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2504000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2504000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3811000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18403000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18403000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,404000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-133000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3982000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-45094000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30402000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30402000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-336000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-79271000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27304000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-52303000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-52303000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,115971000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,115971000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,115971000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33266000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46985000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46985000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,386000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,584000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2774000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7154000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36087000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36087000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-634000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46646000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31683000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15597000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15597000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,153123000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,21386000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,174509000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,174509000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,122825000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27326000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27326000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,442000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,393000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4094000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2903000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-287000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-91829000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40340000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51776000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51776000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2476000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2476000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2476000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 15:52:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-74600000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32591000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32591000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6844000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25747000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25747000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-684000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89036000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68421000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21299000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21299000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-2476000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3628000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1152000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1152000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-45894000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33938000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33938000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,465000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,649000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3257000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3072000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26495000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26391000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-375000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49734000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73813000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23704000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23704000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,917000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,917000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,917000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1770000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32925000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32925000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3544000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36469000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36469000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-408000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19165000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69550000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,49977000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,49977000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,374000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,754000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1128000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1128000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14636000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42266000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42266000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,468000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1731000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2901000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-587000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43555000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43555000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-176000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12536000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41172000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28460000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28460000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1952000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1952000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1952000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q1,2014-01-01,2014-03-31,2014-05-06 15:56:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13143000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,452000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3309000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9696000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5422000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29989000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29989000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60574000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,60479000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,60479000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-446000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,393000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,108000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30545000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,103216000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,103216000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,447000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4703000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3656000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,133529000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,238239000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,238239000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-93000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9253000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6965000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1030000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,913000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-117000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-117000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,235741000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40342000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40342000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,406000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1163000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3076000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11283000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46980000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46980000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-998000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32293000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31295000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31295000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,482000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,443000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,908000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1833000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1833000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13852000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-93302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-93302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,354000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,719000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2915000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4514000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-99658000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-99658000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1112000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15248000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14136000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14136000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1162000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1162000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1162000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-84360000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 15:44:27+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38428000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38428000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,614000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-72000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3753000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2288000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31845000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31845000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2857000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-64440000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10011000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57286000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57286000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,472000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,221000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,693000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,693000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-88438000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,99000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,175000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,42544000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42544000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,589000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-126143000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,48092000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34918000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34918000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1447000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39046000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37599000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37599000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2677000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,312000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39190000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39190000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,735000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,272000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,133176000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12225000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,82768000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,82768000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1010000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57016000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25674000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-32352000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-32352000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2358000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1888000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,470000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,470000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50886000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,310000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,710000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40664000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40664000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,693000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3771000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15673000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51873000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51873000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-270000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34323000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12110000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22483000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22483000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-59000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-59000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-59000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-74415000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:00:04+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,309000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,52991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,693000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-106572000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6461000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46427000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46427000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-368000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5369000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60444000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,54707000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,54707000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,462000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-146000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,316000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,316000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8596000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,307000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19498000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19498000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1180000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1322000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18092000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35088000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35088000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12798000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1146000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23024000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11349000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11349000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-105000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-105000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-105000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23844000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,305000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22930000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22930000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,852000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,159000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2862000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1919000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20968000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20968000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14013000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,994000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9775000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3244000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3244000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-130000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-105000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-235000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-235000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24447000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,304000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10475000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10475000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,692000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1814000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9206000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17175000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17175000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-108000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-108000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-108000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,717000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 15:36:15+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,302000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16954000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16954000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,692000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3880000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2675000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9707000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9707000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,70000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-110000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-40000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-40000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9747000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,300000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7105000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7105000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,261000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6804000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10997000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11037000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11037000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21987000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22013000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22013000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-8000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-74000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-82000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-82000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-33132000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,200000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9451000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9451000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,958000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-825000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9255000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9255000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5744000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11530000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5786000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5786000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3437000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-563000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-563000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:16:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4032000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6963000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6963000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,53000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,946000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1138000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4826000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4826000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17260000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17260000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17260000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6156000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6156000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6156000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18590000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13381000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,45000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,839000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21256000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6991000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9942000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9942000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9942000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-16000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-16000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-16000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16949000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8220000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8220000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,843000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23705000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16358000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16358000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16400000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13744000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13744000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,888000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2829000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15675000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15675000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12579000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7612000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7612000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27618000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,27618000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,27618000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 07:24:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4331000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10514000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10514000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1742000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1612000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7152000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7161000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9182000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2873000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2873000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,27000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,27000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10007000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11417000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11417000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,64000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1295000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,230000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9828000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9819000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1336000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15920000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11256000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11256000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,38000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,38000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21037000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11382000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11382000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,137000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,364000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2006000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8875000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8875000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-767000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4183000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14450000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9500000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47000.0
Infinity Pharmaceuticals Inc,INFI,,0001113148,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,672000.0
